News

Find News

Filter articles

Showing 2381 to 2390 of 2651 results

Acura settles Oxecta dispute with Ranbaxy

US08-05-2014Legal developments

Acura Pharmaceuticals and Ranbaxy have agreed to settle their patent infringement litigation related to painkiller Aversion (oxycodone hydrochloride), once marketed by Pfizer under its registered trademark Oxecta.

FTC weighs in on “no-authorised-generic” antitrust case

US07-05-2014

The US Federal Trade Commission (FTC) has filed an amicus brief in an antitrust case that concerns a “no-authorised-generic” settlement between Teva and GlaxoSmithKline (GSK).

Allergan sues Aurobindo over eye drop generic

US06-05-2014Legal developments

Allergan, along with Japan-based Senju and Kyorin have sued Indian pharma Aurobindo for infringing claims in the Japanese pharmaceutical companies’ reexamined US patent 6,333,045.

Bayer buys Merck’s consumer care arm for $14.2bn

Germany, US06-05-2014Mergers & acquisitions

Bayer AG has agreed to buy New Jersey-based Merck’s consumer care business for $14.2 billion, the companies announced today (May 6).

HGF promotes Nelson to partner

UK01-05-2014

HGF has promoted Mike Nelson to partner. He joined the firm last year to work with the pharmaceutical and chemistry teams after arriving from AstraZeneca.

US hits out at Indian pharma patent protection

India, US01-05-2014

Patent protection in the pharmaceutical sector in India has raised “serious” concerns, the US government said yesterday, April 30, in its annual Special 301 Report.

Cephalon launches another Treanda action

01-05-2014

Cephalon has filed another lawsuit to protect its chronic lymphocytic leukaemia and non-Hodgkin’s lymphoma treatment Treanda (bendamustine hydrochloride), this time against Canadian pharmaceutical company Uman Pharma.

Actavis and Pfizer settle Celebrex litigation

US29-04-2014Legal developments

Actavis has entered into an agreement with Pfizer to settle all outstanding patent litigation related to Pfizer’s arthritis drug Celebrex (celecoxib).

AstraZeneca ‘has value’ says former Pfizer lawyer

UK, US28-04-2014Mergers & acquisitions

AstraZeneca’s portfolio does not appear to offer a long pipeline of marketed products with long periods of exclusivity, says Jason Rutt, head of the patents group at Rouse in London and former head of Pfizer’s UK patent department.

Federal Circuit rules against Roche in Tamiflu case

India, US25-04-2014Legal developments

The US Court of Appeals for the Federal Circuit has thrown out a lower court ruling that found Natco Pharma infringed a patent covering Roche’s flu drug Tamiflu (oseltamivir phosphate).

Showing 2381 to 2390 of 2651 results

LSIPR